ArticleThe Journal of biological chemistry2015

Combining valosin-containing protein (VCP) inhibition and suberanilohydroxamic acid (SAHA) treatment additively enhances the folding, trafficking, and function of epilepsy-associated γ-aminobutyric acid, type A (GABAA) receptors.

Dong-Yun Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.